FinalDose
Latest round
- Seed
Last raised
- Jun 2026
Total raised
- Undisclosed
Investors
- 2
About FinalDose
FinalDose, founded in 2025 and headquartered in San Francisco, US, specializes in biotechnology focused on cancer therapies.FinalDose specializes in advanced cancer therapy solutions, focusing on a comprehensive architecture that leverages DNA targeting, programmable delivery, and elimination mechanisms to address various forms of cancer. The company’s core product offerings are designed to precisely target cancer cells while minimizing damage to healthy tissues, thereby enhancing therapeutic efficacy and patient safety. Their solutions are aimed at healthcare providers, oncology clinics, and research institutions, with an emphasis on customizable treatments that can be tailored to individual patient profiles.FinalDose generates revenue primarily through direct partnerships with oncology clinics and healthcare providers, facilitating the distribution of their cancer therapy solutions. The company's transactional structure involves B2B engagements, where healthcare institutions purchase therapies on a per-patient basis or through subscription models that allow for ongoing access to their technology. The company offers a range of products, including flagship therapies that have been designed for specific cancer treatments. Pricing structures are determined based on the complexity and customization of the therapies, ensuring that clients receive tailored solutions for their patient populations. The company is focused on developing new cancer therapies and will strategically expand into additional markets, including Europe and Asia, by 2027. This expansion aims to increase the accessibility of their innovative therapeutic solutions in response to the growing global demand.
Who invested in FinalDose
2 investors across 1 round
See all investors in FinalDose
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Jun 2, 2026
Amount
Undisclosed
Investors
Questions about FinalDose
Who invested in FinalDose?
FinalDose has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has FinalDose raised?
FinalDose has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did FinalDose last raise money?
FinalDose's most recent round on record is a Seed, in Jun 2026.
What does FinalDose do?
FinalDose, founded in 2025 and headquartered in San Francisco, US, specializes in biotechnology focused on cancer therapies.
Where is FinalDose headquartered?
FinalDose is headquartered in San Francisco, US.
Which VCs invest in companies like FinalDose?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at FinalDose's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like FinalDose? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.